Important safety considerations for tirzepatide include its boxed warning for thyroid C-cell tumors (contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), risk of pancreatitis, gallbladder disease, and potential complications in patients with diabetic retinopathy
That's something that should be reconsidered
Multiple GLP-1 drugs linked to lower AFib risk GLP-1 receptor agonists (GLP-1-RAs) may be able to reduce a patient's risk of atrial fibrillation (AFib), according to new data presented at Heart Rhythm 2026 in Chicago
Results indicated that shorter pre-dose fasting times compared with an overnight pre-dose fast resulted in significantly lower semaglutide AUC 024 h and C max after the 10th dose
H-L: A stark conversation with incoming AG leads KY opioid commission chair to resign Bryan Hubbard, outgoing director of the Kentucky Opioid Abatement Advisory Commission, sent his resignation letter late Tuesday night, Dec
1:12:20: Attia says genetic testing is a little over-hyped and not a panacea
